Started March 2026
RESTOR
NCT06658093
A 194-participant study of rapamycin and everolimus in generally healthy adults ages 65–90, including longer placebo-controlled arms.
View the official study record
Speculative horizon · January 1, 2045
Follow the race toward longevity escape velocity
What if medicine begins
outrunning aging?
Farshore is a research and self-tracking workspace for people following a bold hypothesis: that advances across AI, quantum computing, and medicine could one day extend healthy life faster than time passes.
Track biomarkers. Follow emerging human research. Explore the protocols discussed at the frontier—with evidence and uncertainty kept in view.
A horizon, not a promise. 2045 is an illustrative date associated with futurist forecasts. There is no scientific consensus that LEV will occur—or when. This countdown does not predict your lifespan or a medical outcome. Farshore is informational and educational, not medical advice.
2045
Illustrative horizon
150+
Biomarker catalog
Human → preprint
Evidence lens
Zero
Promises made
The Farshore Thesis
A field guide for people following
the convergence.
Longevity escape velocity is the hypothesis that medicine could eventually add healthy life faster than time takes it away. It is an idea worth watching, not an established scientific outcome.
The interesting story is already unfolding across AI, quantum and advanced computing, drug discovery, cellular biology, and clinical medicine. Some signals are promising. Many will fail. No one knows whether those curves will produce LEV, or on what timeline.
Farshore gives longevity enthusiasts one place to follow that story, organize personal biomarkers, and understand the ideas and protocols discussed at the frontier without turning a bold forecast into a promise.
AI-assisted discoveryQuantum & advanced computingRegenerative medicineHuman longevity trials
Your Place on the Timeline
How old would you be in 2045?
Put one widely discussed horizon in personal terms. This is simple calendar math, not a lifespan or biological age prediction.
Calculated in your browser. Your birthday is not saved.
Enter a valid birthday to place yourself on the timeline.
Frontier Trial Watch · Checked September 2026
The hypothesis is futuristic.
The experiments are happening now.
Farshore follows registered human studies as they move from ideas to measurable results. Here are three trials worth watching this year.
A trial underway is not evidence that an intervention works, is safe, or brings LEV closer. Following research is not medical advice.
Active human study
EVERLAST
NCT05835999
A randomized, placebo-controlled study of low-dose everolimus across metabolic, cardiac, cognitive, and physical measures in older adults.
View the official study recordActive human study
SENIOR
NCT06018467
A randomized clinical trial studying senolytic and antioxidant strategies in osteoporosis and skeletal aging.
View the official study recordThe Platform
Follow the frontier. Keep your own signal in view.
Farshore connects the future-facing story to a grounded personal workspace: research, biomarkers, routines, and questions in one place.
Evidence
Research Watch
Follow longevity studies with dates, source links, and evidence context so early findings do not look like settled medicine.
Personal
Biomarker Timeline
Bring lab results and health markers into one longitudinal record. Confirm extracted values before they become part of your history.
Review first
Plan Proposals
Use AI to turn your goals and records into a plan you can inspect, edit, and discuss with a qualified clinician before accepting changes.
Context
Supplement Explorer
Learn what people at the frontier discuss, then compare the quality of evidence, cautions, and possible interactions.
Long view
LEV Watch
Track the technologies behind longevity forecasts while keeping scenarios, preprints, animal research, and human results distinct.
Longitudinal
Health Progress
See your measurements, routines, and check-ins over time. Farshore shows the record; it does not manufacture a promised trajectory.
How It Works
Curiosity, organized.
Start with the questions that brought you here. Farshore helps you keep the science, your data, and the uncertainty connected.
01Orient
Choose what you want to follow
Set your interests across biomarkers, supplements, emerging therapies, and the technologies shaping the LEV conversation.
02Record
Build a personal baseline
Add the labs, habits, goals, and routines you want in view. Review imported values before saving them.
03Explore
Compare ideas with evidence
Use research links and AI-assisted summaries to understand what is established, preliminary, or still speculative.
04Revisit
Update as the field moves
Track your record over time and revise your thinking as new human results arrive. Your clinician remains the source for medical decisions.
People and Ideas to Follow
Map the conversation without copying the prescription.
Explore the themes prominent longevity voices discuss, then go back to the evidence and your own medical context.
David Sinclair
Epigenetic aging, NAD biology, and cellular reprogramming
EpigeneticsNAD biologyReprogramming
Peter Attia
Medicine 3.0, exercise, and metabolic and cardiovascular risk
HealthspanExerciseRisk
Andrew Huberman
Sleep, circadian rhythms, behavior, and performance
SleepBehaviorPerformance
Rhonda Patrick
Micronutrients, nutrition, sauna, and inflammation
NutritionMicronutrientsSauna
Bryan Johnson
Quantified self, repeated measurement, and structured routines
MeasurementRoutineQuantified self
Peter Diamandis
LEV forecasts, exponential technologies, and future medicine
LEVExponential techForecasts
These are editorial summaries of public conversations. No affiliation or endorsement is implied, and Farshore does not recommend copying any public figure's supplement, medication, or treatment regimen.
Pricing
Start free. Upgrade when you're serious.
Full biomarker tracking and research access on the free tier. Upgrade to Pro for AI-powered protocol generation, lab extraction, and personalized recommendations.
Free
$0/forever
Track biomarkers, browse research, and see your trajectory. Everything you need to get started.
Get startedMost popular
Pro
$19.99/month
or $149/year (save 38% — $12.42/mo effective)
AI builds your daily longevity protocol from your biomarkers. Upload lab PDFs and watch 40+ values populate in seconds. Personalized supplement picks. The full intelligence engine.
Start ProFeature
Free
Pro
Profile & onboarding
Biomarker tracking (manual entry)
Research feed (full access)
Supplement catalog + purchase links
Trajectory visualization
Protocol check-ins + streaks
History (last 30 days)
AI Daily Protocol
Your personal longevity plan — AI analyzes your age, biomarkers, goals, and current stack to generate a daily protocol across supplements, nutrition, exercise, recovery, skincare, and more. Review proposed changes and track your consistency.
Lab PDF Upload + AI Extraction
Drop a PDF or snap a photo of your lab results — AI extracts results for you to review and confirm before they enter your record.
AI Lab Summary
A plain-English, research-based analysis of your full biomarker panel: what's in range, what needs attention, and what your current supplements are already addressing.
AI Supplement Recommendations
Personalized suggestions for supplements to add — based on your out-of-range biomarkers, goals, and what you're already taking. Review cautions and discuss changes with your clinician.
Full History (90 days + all-time)
Shareable Trajectory Cards
Expert Framework Presets (Sinclair, Attia, Huberman)
Read This First
Bold thesis. Clear boundaries.
Farshore is an informational and educational workspace for longevity and LEV enthusiasts. It brings together emerging research, personal biomarker records, supplement context, routines, and future-facing scenarios so you can follow the field with its uncertainty intact.
Keep watch
The frontier is moving.
Follow it with your eyes open.
Build your baseline, follow human research, and explore the LEV thesis without mistaking a compelling future for a guaranteed one.
Join FarshoreFree tier · No card required
Field Notes
Notes from the longevity frontier.
Occasional summaries of notable human studies, emerging ideas, and the technologies shaping the LEV conversation.
No fixed schedule. Unsubscribe anytime.